|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 237 for Hspg2

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.054s

Categories

Category: Publication
Type Details Score
Publication
First Author: Gerdes Gyuricza I
Year: 2020
Journal: Eur J Hum Genet
Title: Is HSPG2 a modifier gene for Marfan syndrome?
Volume: 28
Issue: 9
Pages: 1292-1296
Publication
First Author: Hayes AJ
Year: 2013
Journal: Histochem Cell Biol
Title: Comparative immunolocalisation of fibrillin-1 and perlecan in the human foetal, and HS-deficient hspg2 exon 3 null mutant mouse intervertebral disc.
Volume: 139
Issue: 1
Pages: 1-11
Publication
First Author: Shu CC
Year: 2019
Journal: Biochem J
Title: Elevated hypertrophy, growth plate maturation, glycosaminoglycan deposition, and exostosis formation in the Hspg2 exon 3 null mouse intervertebral disc.
Volume: 476
Issue: 2
Pages: 225-243
Publication
First Author: Rodgers KD
Year: 2007
Journal: Hum Mol Genet
Title: Reduced perlecan in mice results in chondrodysplasia resembling Schwartz-Jampel syndrome.
Volume: 16
Issue: 5
Pages: 515-28
Publication
First Author: Nakamura K
Year: 2019
Journal: J Cell Biol
Title: Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier.
Volume: 218
Issue: 10
Pages: 3506-3525
Publication
First Author: Arikawa-Hirasawa E
Year: 2001
Journal: Nat Genet
Title: Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.
Volume: 27
Issue: 4
Pages: 431-4
Publication  
First Author: Hayes AJ
Year: 2016
Journal: Eur Cell Mater
Title: Pericellular colocalisation and interactive properties of type VI collagen and perlecan in the intervertebral disc.
Volume: 32
Pages: 40-57
Publication  
First Author: Shu CC
Year: 2018
Journal: PeerJ
Title: Achilles and tail tendons of perlecan exon 3 null heparan sulphate deficient mice display surprising improvement in tendon tensile properties and altered collagen fibril organisation compared to C57BL/6 wild type mice.
Volume: 6
Pages: e5120
Publication
First Author: Tsiantoulas D
Year: 2021
Journal: Nature
Title: APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans.
Volume: 597
Issue: 7874
Pages: 92-96
Publication
First Author: Noonan DM
Year: 1988
Journal: J Biol Chem
Title: Identification of cDNA clones encoding different domains of the basement membrane heparan sulfate proteoglycan.
Volume: 263
Issue: 31
Pages: 16379-87
Publication  
First Author: Ning L
Year: 2015
Journal: Matrix Biol
Title: Perlecan inhibits autophagy to maintain muscle homeostasis in mouse soleus muscle.
Volume: 48
Pages: 26-35
Publication
First Author: Gotha L
Year: 2014
Journal: Am J Physiol Heart Circ Physiol
Title: Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury.
Volume: 307
Issue: 3
Pages: H337-45
Publication
First Author: Tran-Lundmark K
Year: 2008
Journal: Circ Res
Title: Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation.
Volume: 103
Issue: 1
Pages: 43-52
Publication
First Author: Shu CC
Year: 2016
Journal: Arthritis Rheumatol
Title: Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
Volume: 68
Issue: 4
Pages: 868-79
Publication  
First Author: Gubbiotti MA
Year: 2017
Journal: Matrix Biol
Title: A current view of perlecan in physiology and pathology: A mosaic of functions.
Volume: 57-58
Pages: 285-298
Publication
First Author: Tran PK
Year: 2004
Journal: Circ Res
Title: Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
Volume: 94
Issue: 4
Pages: 550-8
Publication
First Author: Wang B
Year: 2014
Journal: J Bone Miner Res
Title: Perlecan-containing pericellular matrix regulates solute transport and mechanosensing within the osteocyte lacunar-canalicular system.
Volume: 29
Issue: 4
Pages: 878-91
Publication  
First Author: Pei S
Year: 2020
Journal: Bone
Title: Perlecan/Hspg2 deficiency impairs bone's calcium signaling and associated transcriptome in response to mechanical loading.
Volume: 131
Pages: 115078
Publication
First Author: Kvist AJ
Year: 2006
Journal: J Biol Chem
Title: Chondroitin sulfate perlecan enhances collagen fibril formation. Implications for perlecan chondrodysplasias.
Volume: 281
Issue: 44
Pages: 33127-39
Publication
First Author: Bangratz M
Year: 2012
Journal: Am J Pathol
Title: A mouse model of Schwartz-Jampel syndrome reveals myelinating Schwann cell dysfunction with persistent axonal depolarization in vitro and distal peripheral nerve hyperexcitability when perlecan is lacking.
Volume: 180
Issue: 5
Pages: 2040-55
Publication
First Author: Xu X
Year: 2016
Journal: Dev Biol
Title: Knockdown of the pericellular matrix molecule perlecan lowers in situ cell and matrix stiffness in developing cartilage.
Volume: 418
Issue: 2
Pages: 242-7
Publication
First Author: Yamashita Y
Year: 2018
Journal: Sci Rep
Title: Perlecan, a heparan sulfate proteoglycan, regulates systemic metabolism with dynamic changes in adipose tissue and skeletal muscle.
Volume: 8
Issue: 1
Pages: 7766
Publication
First Author: Kaneko H
Year: 2013
Journal: Matrix Biol
Title: Synovial perlecan is required for osteophyte formation in knee osteoarthritis.
Volume: 32
Issue: 3-4
Pages: 178-87
Publication
First Author: Inomata T
Year: 2012
Journal: Invest Ophthalmol Vis Sci
Title: Perlecan-deficient mutation impairs corneal epithelial structure.
Volume: 53
Issue: 3
Pages: 1277-84
Publication
First Author: Xu Z
Year: 2010
Journal: Matrix Biol
Title: Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition.
Volume: 29
Issue: 6
Pages: 461-70
Publication
First Author: Ida-Yonemochi H
Year: 2005
Journal: J Histochem Cytochem
Title: Perlecan, a basement membrane-type heparan sulfate proteoglycan, in the enamel organ: its intraepithelial localization in the stellate reticulum.
Volume: 53
Issue: 6
Pages: 763-72
Publication
First Author: Hart M
Year: 2001
Journal: J Pathol
Title: Overproduction of perlecan core protein in cultured cells and transgenic mice.
Volume: 194
Issue: 2
Pages: 262-9
Publication
First Author: Olsen BR
Year: 1999
Journal: J Cell Biol
Title: Life without perlecan has its problems.
Volume: 147
Issue: 5
Pages: 909-12
Publication
First Author: Tapanadechopone P
Year: 1999
Journal: Biochem Biophys Res Commun
Title: Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan.
Volume: 265
Issue: 3
Pages: 680-90
Publication
First Author: Ledbetter SR
Year: 1985
Journal: J Biol Chem
Title: Identification of the precursor protein to basement membrane heparan sulfate proteoglycans.
Volume: 260
Issue: 13
Pages: 8106-113
Publication
First Author: Kallunki P
Year: 1991
Journal: Genomics
Title: Cloning of human heparan sulfate proteoglycan core protein, assignment of the gene (HSPG2) to 1p36.1----p35 and identification of a BamHI restriction fragment length polymorphism.
Volume: 11
Issue: 2
Pages: 389-96
Publication
First Author: Ailles L
Year: 1993
Journal: Lab Invest
Title: Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
Volume: 69
Issue: 4
Pages: 443-8
Publication  
First Author: Iozzo RV
Year: 1994
Journal: Biochem J
Title: The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices.
Volume: 302 ( Pt 3)
Pages: 625-39
Publication
First Author: Costell M
Year: 1996
Journal: FEBS Lett
Title: Structural characterization of recombinant domain II of the basement membrane proteoglycan perlecan.
Volume: 396
Issue: 2-3
Pages: 127-31
Publication
First Author: Joseph SJ
Year: 1996
Journal: Development
Title: A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant.
Volume: 122
Issue: 11
Pages: 3443-52
Publication
First Author: Handler M
Year: 1997
Journal: Dev Dyn
Title: Developmental expression of perlecan during murine embryogenesis.
Volume: 210
Issue: 2
Pages: 130-45
Publication  
First Author: Parajuli A
Year: 2020
Journal: Biomolecules
Title: Trabecular Bone Deficit and Enhanced Anabolic Response to Re-Ambulation after Disuse in Perlecan-Deficient Skeleton.
Volume: 10
Issue: 2
Publication
First Author: Brown AJ
Year: 2008
Journal: Bone
Title: Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation.
Volume: 43
Issue: 4
Pages: 689-99
Publication
First Author: Noonan DM
Year: 1991
Journal: J Biol Chem
Title: The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule.
Volume: 266
Issue: 34
Pages: 22939-47
Publication
First Author: Costell M
Year: 2002
Journal: Circ Res
Title: Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice.
Volume: 91
Issue: 2
Pages: 158-64
Publication
First Author: Sage J
Year: 2012
Journal: PLoS One
Title: Cleavage of nidogen-1 by cathepsin S impairs its binding to basement membrane partners.
Volume: 7
Issue: 8
Pages: e43494
Publication
First Author: Smith SE
Year: 1997
Journal: Dev Biol
Title: Expression of heparan sulfate proteoglycan (perlecan) in the mouse blastocyst is regulated during normal and delayed implantation.
Volume: 184
Issue: 1
Pages: 38-47
Publication
First Author: Kvansakul M
Year: 2001
Journal: EMBO J
Title: Structural basis for the high-affinity interaction of nidogen-1 with immunoglobulin-like domain 3 of perlecan.
Volume: 20
Issue: 19
Pages: 5342-6
Publication
First Author: Hall M
Year: 2001
Journal: J Anat
Title: Effects of the curly tail genotype on neuroepithelial integrity and cell proliferation during late stages of primary neurulation.
Volume: 199
Issue: Pt 6
Pages: 645-55
Publication
First Author: Rossi M
Year: 2003
Journal: EMBO J
Title: Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney.
Volume: 22
Issue: 2
Pages: 236-45
Publication
First Author: Bishop JR
Year: 2010
Journal: PLoS One
Title: Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans.
Volume: 5
Issue: 11
Pages: e13919
Publication
First Author: Stum M
Year: 2008
Journal: Hum Mol Genet
Title: Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia.
Volume: 17
Issue: 20
Pages: 3166-79
Publication
First Author: Kanekiyo T
Year: 2011
Journal: J Neurosci
Title: Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake.
Volume: 31
Issue: 5
Pages: 1644-51
Publication
First Author: French MM
Year: 1999
Journal: J Cell Biol
Title: Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro.
Volume: 145
Issue: 5
Pages: 1103-15
Publication
First Author: San Martin S
Year: 2004
Journal: Am J Reprod Immunol
Title: Perlecan and syndecan-4 in uterine tissues during the early pregnancy in mice.
Volume: 52
Issue: 1
Pages: 53-9
Publication
First Author: Xu Y
Year: 2004
Journal: J Biol Chem
Title: Angiopoietin-3 is tethered on the cell surface via heparan sulfate proteoglycans.
Volume: 279
Issue: 39
Pages: 41179-88
Publication
First Author: Tiedemann K
Year: 2005
Journal: J Biol Chem
Title: Microfibrils at basement membrane zones interact with perlecan via fibrillin-1.
Volume: 280
Issue: 12
Pages: 11404-12
Publication
First Author: Mikedis MM
Year: 2009
Journal: Dev Dyn
Title: Collagen type IV and Perlecan exhibit dynamic localization in the Allantoic Core Domain, a putative stem cell niche in the murine allantois.
Volume: 238
Issue: 12
Pages: 3193-204
Publication
First Author: O'Shea KS
Year: 1987
Journal: Development
Title: Differential deposition of basement membrane components during formation of the caudal neural tube in the mouse embryo.
Volume: 99
Issue: 4
Pages: 509-19
Publication
First Author: Allen JM
Year: 2006
Journal: J Biol Chem
Title: WARP is a novel multimeric component of the chondrocyte pericellular matrix that interacts with perlecan.
Volume: 281
Issue: 11
Pages: 7341-9
Publication
First Author: Cormier RT
Year: 2000
Journal: Oncogene
Title: The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64.
Volume: 19
Issue: 28
Pages: 3182-92
Publication
First Author: Coulson-Thomas VJ
Year: 2015
Journal: Invest Ophthalmol Vis Sci
Title: Loss of corneal epithelial heparan sulfate leads to corneal degeneration and impaired wound healing.
Volume: 56
Issue: 5
Pages: 3004-14
Publication
First Author: Celie JW
Year: 2007
Journal: Am J Pathol
Title: Subendothelial heparan sulfate proteoglycans become major L-selectin and monocyte chemoattractant protein-1 ligands upon renal ischemia/reperfusion.
Volume: 170
Issue: 6
Pages: 1865-78
Publication
First Author: González-Iriarte M
Year: 2003
Journal: J Mol Cell Cardiol
Title: Development of the coronary arteries in a murine model of transposition of great arteries.
Volume: 35
Issue: 7
Pages: 795-802
Publication  
First Author: Gustafsson E
Year: 2003
Journal: Ann N Y Acad Sci
Title: Role of collagen type II and perlecan in skeletal development.
Volume: 995
Pages: 140-50
Publication
First Author: Julian J
Year: 2001
Journal: Biol Reprod
Title: Expression of heparin/heparan sulfate interacting protein/ribosomal protein l29 during the estrous cycle and early pregnancy in the mouse.
Volume: 64
Issue: 4
Pages: 1165-75
Publication
First Author: Chakravarti S
Year: 1991
Journal: Mamm Genome
Title: Assignment of the perlecan (heparan sulfate proteoglycan) gene to mouse chromosome 4.
Volume: 1
Issue: 4
Pages: 270-2
Publication
First Author: Bai XM
Year: 1994
Journal: J Histochem Cytochem
Title: Differential expression of multiple cell-surface heparan sulfate proteoglycans during embryonic tooth development.
Volume: 42
Issue: 8
Pages: 1043-54
Publication
First Author: Sharma B
Year: 1998
Journal: J Clin Invest
Title: Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo.
Volume: 102
Issue: 8
Pages: 1599-608
Publication
First Author: Garl PJ
Year: 2004
Journal: Circ Res
Title: Perlecan-induced suppression of smooth muscle cell proliferation is mediated through increased activity of the tumor suppressor PTEN.
Volume: 94
Issue: 2
Pages: 175-83
Publication
First Author: Shibata S
Year: 2007
Journal: J Periodontol
Title: Immunohistochemical localization of syndecan-1 in the dental follicle of postnatal mouse teeth.
Volume: 78
Issue: 7
Pages: 1322-8
Publication
First Author: Wade A
Year: 2013
Journal: FEBS J
Title: Proteoglycans and their roles in brain cancer.
Volume: 280
Issue: 10
Pages: 2399-417
Publication
First Author: Fujikawa K
Year: 2015
Journal: Eur J Histochem
Title: An in situ hybridization study of perlecan, DMP1, and MEPE in developing condylar cartilage of the fetal mouse mandible and limb bud cartilage.
Volume: 59
Issue: 3
Pages: 2553
Publication
First Author: Allen JM
Year: 2008
Journal: Matrix Biol
Title: The extracellular matrix protein WARP is a novel component of a distinct subset of basement membranes.
Volume: 27
Issue: 4
Pages: 295-305
Publication
First Author: Mammoto T
Year: 2011
Journal: Dev Cell
Title: Mechanochemical control of mesenchymal condensation and embryonic tooth organ formation.
Volume: 21
Issue: 4
Pages: 758-69
Publication
First Author: Kanagawa M
Year: 2005
Journal: FEBS Lett
Title: Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.
Volume: 579
Issue: 21
Pages: 4792-6
Publication
First Author: Nyström A
Year: 2009
Journal: Blood
Title: Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity.
Volume: 114
Issue: 23
Pages: 4897-906
Publication
First Author: Vikramadithyan RK
Year: 2004
Journal: J Lipid Res
Title: Atherosclerosis in perlecan heterozygous mice.
Volume: 45
Issue: 10
Pages: 1806-12
Publication
First Author: Shi Y
Year: 2013
Journal: Invest Ophthalmol Vis Sci
Title: Development, composition, and structural arrangements of the ciliary zonule of the mouse.
Volume: 54
Issue: 4
Pages: 2504-15
Publication
First Author: Harunaga JS
Year: 2014
Journal: Dev Biol
Title: Local and global dynamics of the basement membrane during branching morphogenesis require protease activity and actomyosin contractility.
Volume: 394
Issue: 2
Pages: 197-205
Publication
First Author: Holtz AM
Year: 2015
Journal: J Cell Biol
Title: Secreted HHIP1 interacts with heparan sulfate and regulates Hedgehog ligand localization and function.
Volume: 209
Issue: 5
Pages: 739-57
Publication
First Author: Colombelli C
Year: 2015
Journal: J Cell Biol
Title: Perlecan is recruited by dystroglycan to nodes of Ranvier and binds the clustering molecule gliomedin.
Volume: 208
Issue: 3
Pages: 313-29
Publication
First Author: Lee B
Year: 2011
Journal: J Clin Invest
Title: Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents.
Volume: 121
Issue: 8
Pages: 3005-23
Publication
First Author: Barnette DN
Year: 2014
Journal: PLoS One
Title: RNA-seq analysis to identify novel roles of scleraxis during embryonic mouse heart valve remodeling.
Volume: 9
Issue: 7
Pages: e101425
Publication
First Author: Salmivirta K
Year: 2002
Journal: Exp Cell Res
Title: Binding of mouse nidogen-2 to basement membrane components and cells and its expression in embryonic and adult tissues suggest complementary functions of the two nidogens.
Volume: 279
Issue: 2
Pages: 188-201
Publication
First Author: Miosge N
Year: 2003
Journal: J Histochem Cytochem
Title: The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo.
Volume: 51
Issue: 3
Pages: 285-96
Publication
First Author: Olguin H
Year: 2001
Journal: Dev Dyn
Title: Expression and localization of proteoglycans during limb myogenic activation.
Volume: 221
Issue: 1
Pages: 106-15
Publication
First Author: Patel VN
Year: 2007
Journal: Development
Title: Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis.
Volume: 134
Issue: 23
Pages: 4177-86
Publication
First Author: Ida-Yonemochi H
Year: 2013
Journal: Gene Expr Patterns
Title: Reciprocal expressions between α-dystroglycan and integrin β1, perlecan receptors, in the murine enamel organ development.
Volume: 13
Issue: 8
Pages: 293-302
Publication
First Author: Han X
Year: 2018
Journal: J Biol Chem
Title: The transcription factor NKX2-3 mediates p21 expression and ectodysplasin-A signaling in the enamel knot for cusp formation in tooth development.
Volume: 293
Issue: 38
Pages: 14572-14584
Publication  
First Author: Hirata A
Year: 2013
Journal: Biomed Res Int
Title: Heparanase localization during palatogenesis in mice.
Volume: 2013
Pages: 760236
Publication
First Author: Rautavuoma K
Year: 2004
Journal: Proc Natl Acad Sci U S A
Title: Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice.
Volume: 101
Issue: 39
Pages: 14120-5
Publication
First Author: Kiyozumi D
Year: 2005
Journal: Exp Cell Res
Title: Identification of a novel cell-adhesive protein spatiotemporally expressed in the basement membrane of mouse developing hair follicle.
Volume: 306
Issue: 1
Pages: 9-23
Publication
First Author: Sasse P
Year: 2008
Journal: Cardiovasc Res
Title: Perlecan is critical for heart stability.
Volume: 80
Issue: 3
Pages: 435-44
Publication
First Author: Henderson DJ
Year: 1997
Journal: Mech Dev
Title: Over-expression of the chondroitin sulphate proteoglycan versican is associated with defective neural crest migration in the Pax3 mutant mouse (splotch).
Volume: 69
Issue: 1-2
Pages: 39-51
Publication
First Author: Monkley SJ
Year: 2000
Journal: Dev Dyn
Title: Disruption of the talin gene arrests mouse development at the gastrulation stage.
Volume: 219
Issue: 4
Pages: 560-74
Publication
First Author: Sebastiani G
Year: 2006
Journal: Hum Mol Genet
Title: Mapping genetic modulators of amyloid plaque deposition in TgCRND8 transgenic mice.
Volume: 15
Issue: 15
Pages: 2313-23
Publication
First Author: Willem M
Year: 2002
Journal: Development
Title: Specific ablation of the nidogen-binding site in the laminin gamma1 chain interferes with kidney and lung development.
Volume: 129
Issue: 11
Pages: 2711-22
Publication
First Author: Noakes PG
Year: 1995
Journal: Nat Genet
Title: The renal glomerulus of mice lacking s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1.
Volume: 10
Issue: 4
Pages: 400-6
Publication
First Author: Ferry A
Year: 2014
Journal: Neuromuscul Disord
Title: Advances in the understanding of skeletal muscle weakness in murine models of diseases affecting nerve-evoked muscle activity, motor neurons, synapses and myofibers.
Volume: 24
Issue: 11
Pages: 960-72
Publication
First Author: Schéele S
Year: 2005
Journal: Proc Natl Acad Sci U S A
Title: Laminin alpha1 globular domains 4-5 induce fetal development but are not vital for embryonic basement membrane assembly.
Volume: 102
Issue: 5
Pages: 1502-6
Publication
First Author: Sigoillot SM
Year: 2016
Journal: FASEB J
Title: Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.
Volume: 30
Issue: 6
Pages: 2382-99
Publication
First Author: Gilmour DT
Year: 1998
Journal: EMBO J
Title: Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens.
Volume: 17
Issue: 7
Pages: 1860-70
Publication
First Author: Kubota Y
Year: 1999
Journal: Dev Dyn
Title: Spatial and temporal changes in chondroitin sulfate distribution in the sclerotome play an essential role in the formation of migration patterns of mouse neural crest cells.
Volume: 214
Issue: 1
Pages: 55-65
Publication
First Author: Flügel-Koch C
Year: 2002
Journal: Dev Dyn
Title: Disruption of anterior segment development by TGF-beta1 overexpression in the eyes of transgenic mice.
Volume: 225
Issue: 2
Pages: 111-25